Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling von JANSEN, Maurice P. H. M, FOEKENS, John A, KLIJN, Jan G. M, BERNS, Els M. J. J, VAN STAVEREN, Iris L, DIRKZWAGER-KIEL, Maaike M, RITSTIER, Kirsten, LOOK, Maxime P, MEIJER-VAN GELDER, Marion E, SIEUWERTS, Anieta M, PORTENGEN, Henk, DORSSERS, Lambert C. J

Volltext

Molecular profiling of platinum resistant ovarian cancer von Helleman, Jozien, Jansen, Maurice P.H.M., Span, Paul N., van Staveren, Iris L., Massuger, Leon F.A.G., Meijer‐van Gelder, Marion E., Sweep, Fred C.G.J., Ewing, Patricia C., van der Burg, Maria E.L., Stoter, Gerrit, Nooter, Kees, Berns, Els M.J.J.

Volltext

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer von BERNS, E. M. J. J, KLIJN, J. G. M, SMID, M, VAN STAVEREN, I. L, GRUIS, N. A, FOEKENS, J. A

Volltext

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer von BERNS, E. M. J. J, FOEKENS, J. A, CORNELISSE, C, CLAASSEN, C. J. C, PORTENGEN, H, BAKKER, B, KLIJN, J. G. M, VOSSEN, R, LOOK, M. P, DEVILEE, P, HENZEN-LOGMANS, S. C, VAN STAVEREN, I. L, VAN PUTTEN, W. L. J, INGANÄS, M, MEIJER-VAN GELDER, M. E

Volltext

Combined Vascular Endothelial Growth Factor and TP53 Status Predicts Poor Response to Tamoxifen Therapy in Estrogen Receptor-positive Advanced Breast Cancer von BERNS, Els M. J. J, KLIJN, Jan G. M, BAKKER, Bert, SWEEP, Fred C. G. J, FOEKENS, John A, LOOK, Maxime P, GREBENCHTCHIKOV, Nicolai, VOSSEN, Rolf, PETERS, Harry, GEURTS-MOESPOT, Anneke, PORTENGEN, Henk, VAN STAVEREN, Iris L, MEIJER-VAN GELDER, Marion E

Volltext

Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families von Verhoog, L.C., van den Ouweland, A.M.W., Berns, E., van Veghel-Plandsoen, M.M., van Staveren, I.L., Wagner, A., Bartels, C.C.M., Tilanus-Linthorst, M.M.A., Devilee, P., Seynaeve, C., Halley, D.J.J., Niermeijer, M.F., Klijn, J.G.M., Meijers-Heijboer, H.

Volltext

Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer von Powell, Brenda L., van Staveren, Iris L., Roosken, Paul, Grieu, Fabienne, Berns, Els M.J.J., Iacopetta, Barry

Volltext

Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset von Powell, B. L., Piersma, D., Kevenaar, M. E., van Staveren, I. L., Themmen, A. P. N., Iacopetta, B. J., Berns, E. M. J. J.

Volltext

Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment von Berns, Els M.J.J., Foekens, John A., van Staveren, Iris L., van Putten, Wim L.J., de Koning, Helen Y.W.C.M., Portengen, Henk, Klijn, Jan G.M.

Volltext

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer von BERNS, E. M. J. J, KLIJN, J. G. M, VAN PUTTEN, W. L. J, VAN STAVEREN, I. L, PORTENGEN, H, FOEKENS, J. A

Volltext

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer von Berns, EMJJ, van Staveren, IL, Look, MP, Smid, M, Klijn, JGM, Foekens, JA

Volltext

Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer von BERNS, E. M. J. J, VAN STAVEREN, I. L, KLIJN, J. G. M, FOEKENS, J. A

Volltext

Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast von Kuenen-Boumeester, Vibeke, Henzen-Logmans, Sonja C., Timmermans, Mieke M., van Staveren, Iris L., van Geel, Albertus, Peeterse, Hans J., Bonnema, Jorien, Berns, Els M. J. J.

Volltext

Molecular profiles of BRCA1-mutated and matched sporadic breast tumours: relation with clinico-pathological features von Berns, E M J J, Staveren, I L van, Verhoog, L, Ouweland, A M W van de, Gelder, M Meijer-van, Meijers-Heijboer, H, Portengen, H, Foekens, J A, Dorssers, L C J, Klijn, J G M

Volltext

Sporadic amplification of the insulin-like growth factor 1 receptor gene in human breast tumors von BERNS, E. M. J. J, KLIJN, J. G. M, VAN STAVEREN, I. L, PORTENGEN, H, FOEKENS, J. A

Volltext

Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours von Schuyer, M, van Staveren, IL, Klijn, JGM, vd Burg, MEL, Stoter, G, Henzen-Logmans, SC, Foekens, JA, Berns, EMJJ

Volltext

Expression profiling of BRCA1 associated breast tumors von Berns, EMJJ, van Staveren, IL, Verhoog, L, Foekens, JA, Klijn, JGM

Volltext

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer von Berns, EMJJ, Klijn, JGM, Smid, M, van Staveren, IL, Gruis, NA, Foekens, JA

Volltext

Sous le développement, le genre von Adjamagbo, Agnès, Agarwal, Bina, Alvarez, Sonia E, Benería, Lourdes, Catarino, Christine, Destremau, Blandine, Falquet, Jules, Guérin, Isabelle, Guétat-Bernard, Hélène, Harcourt, Wendy, Jaramillo, Isabel Cristina, Lautier, Bruno, Locoh, Thérèse, Nobre, Miriam, Odebode, Olasunbo, Oso, Laura, Prügl, Elisabeth, Reysoo, Fenneke, Staveren, Irene van, Verschuur, Christine, Vidal, Laurent

Volltext

Oncogenes and growth factor receptors in advanced human ovarian cancer von Berns, PMJJ, Henzen-Logmans, SC, Rodenburg, CJ, Brussee, R., van Staveren, IL, van Uffelen, C., van der Burg, MEL, Klijn, JGM, Foekens, JA

Volltext